The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of …

J Phannajit, N Wonghakaeo, K Takkavatakarn… - Journal of …, 2022 - Springer
Background Besides reducing hyperphosphatemia in chronic kidney disease (CKD)
patients, phosphate lowering agents might provide beneficial effects on clinical and …
被引用次数：12 相关文章

The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of …

J Phannajit, N Wonghakaeo… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Besides reducing hyperphosphatemia in chronic kidney disease (CKD)
patients, phosphate lowering agents might provide beneficial effects on clinical and …

The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of …

J Phannajit, N Wonghakaeo, K Takkavatakarn… - Journal of …, 2021 - europepmc.org
Background Besides reducing hyperphosphatemia in chronic kidney disease (CKD)
patients, phosphate lowering agents might provide beneficial effects on clinical and …